AbbVie Limited — 21 Licensed Medicines in Ireland

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 21 products held by AbbVie Limited

Medicine	Active substance	Licence holder	Status
Acular 0.5% w/v Eye Drops, solution PA1824/015/001	Ketorolac trometamol	AbbVie Limited	Marketed
Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PA1824/007/001	Brimonidine tartrate	AbbVie Limited	Marketed
Betagan 0.5% w/v Unit Dose Eye Drops, Solution PA1824/012/001	Levobunolol hydrochloride	AbbVie Limited	Not marketed
BOTOX 100 Allergan Units powder for solution for injection PA1824/017/001	Botulinum Toxin Type A	AbbVie Limited	Marketed
BOTOX 200 Allergan Units powder for solution for injection PA1824/017/003	Botulinum Toxin Type A	AbbVie Limited	Marketed
BOTOX 50 Allergan Units powder for solution for injection PA1824/017/002	Botulinum Toxin Type A	AbbVie Limited	Marketed
Celluvisc 0.5 % w/v eye drops solution, unit dose PA1824/016/002	Carmellose sodium	AbbVie Limited	Marketed
Celluvisc 1% w/v Eye drops, solution, unit dose PA1824/016/001	Carmellose sodium	AbbVie Limited	Marketed
Combigan 2 mg/ml + 5 mg/ml eye drops, solution PA1824/019/001	Brimonidine tartrate, Timolol Maleate	AbbVie Limited	Not marketed
Duodopa 20 mg/ml + 5 mg/ml intestinal gel PA1824/002/001	Levodopa, Carbidopa	AbbVie Limited	Marketed
EXOCIN (Ofloxacin) 0.3% w/v Eye Drops Solution PA1824/014/001	Ofloxacin	AbbVie Limited	Marketed
FML 0.1% w/v Eye Drops Suspension PA1824/008/001	Fluorometholone	AbbVie Limited	Not marketed
Pred Forte 1% w/v, Eye Drops Suspension PA1824/010/001	Prednisolone acetate	AbbVie Limited	Marketed
Pred Mild Sterile Ophthalmic Suspension, 0.12% w/v, Eye Drops, Suspension PA1824/009/001	Prednisolone acetate	AbbVie Limited	Not marketed
Produodopa 240 mg/ml + 12 mg/ml solution for infusion PA1824/002/003	Foslevodopa, Foscarbidopa	AbbVie Limited	Marketed
Relestat, 0.5 mg/ml, eye drops, solution PA1824/018/001	Epinastine hydrochloride	AbbVie Limited	Not marketed
Sevorane 100% v/v Inhalation Gas PA1824/004/001	Sevoflurane	AbbVie Limited	Marketed
VISTABEL, 4 Allergan Units/0.1ml, Powder for solution for injection PA1824/020/001	Botulinum Toxin Type A	AbbVie Limited	Marketed
Zemplar 1 microgram capsules, soft PA1824/005/001	Paricalcitol	AbbVie Limited	Marketed
Zemplar 2 micrograms capsules, soft PA1824/005/002	Paricalcitol	AbbVie Limited	Marketed
Zemplar 5 micrograms/ml solution for injection PA1824/005/004	Paricalcitol	AbbVie Limited	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.

AbbVie Limited — Licensed Medicines